Search

Your search keyword '"Tahirkheli N"' showing total 35 results

Search Constraints

Start Over You searched for: Author "Tahirkheli N" Remove constraint Author: "Tahirkheli N"
35 results on '"Tahirkheli N"'

Search Results

1. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

2. Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial

3. Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial

4. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

6. Dapagliflozin and cardiovascular outcomes in type 2 diabetes

7. Dapagliflozin and Cardiovascular Outcomes in Type 2 Diabetes

9. Evolocumab and clinical outcomes in patients with cardiovascular disease

10. Edoxaban versus warfarin in patients with atrial fibrillation

11. Impact of Spontaneous Extracranial Bleeding Events on Health State Utility in Patients with Atrial Fibrillation: Results from the ENGAGE AF‐TIMI 48 Trial

12. Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial†

13. Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial

14. Outcomes With Edoxaban Versus Warfarin in Patients With Previous Cerebrovascular Events Findings From ENGAGE AF-TIMI 48 (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)

15. Cardioversion of Atrial Fibrillation in ENGAGE AF-TIMI 48

16. Stroke and Mortality Risk in Patients With Various Patterns of Atrial Fibrillation: Results From the ENGAGE AF-TIMI 48 Trial (Effective Anticoagulation With Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48)

17. Evolocumab and clinical outcomes in patients with cardiovascular disease

18. Long-Term Use of Ticagrelor in Patients with Prior Myocardial Infarction

19. Cerebrovascular events in 21 105 patients with atrial fibrillation randomized to edoxaban versus warfarin: Effective Anticoagulation with Factor Xa Next Generation in Atrial Fibrillation-Thrombolysis in Myocardial Infarction 48

20. Apixaban versus Enoxaparin for Thromboprophylaxis in Medically Ill Patients

22. Treatment of the systemic capillary leak syndrome with terbutaline and theophylline. A case series.

24. Postpartum depression on the neonatal intensive care unit: current perspectives

25. Effects of the high-density lipoprotein mimetic agent CER-001 on coronary atherosclerosis in patients with acute coronary syndromes: a randomized trial†

26. Development of a blood-based gene expression algorithm for assessment of obstructive coronary artery disease in non-diabetic patients

28. Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial

29. Evacetrapib and Cardiovascular Outcomes in High-Risk Vascular Disease

30. Evaluation of long-term survival after successful percutaneous coronary intervention among patients with chronic renal failure.

31. Sudden cardiac death after coronary artery bypass graft surgery and role of antiplatelet therapy.

32. Bleeding and Ischemic Risk Prediction in Patients With High Bleeding Risk (an EVOLVE Short DAPT Analysis).

33. Primary Results of the EVOLVE Short DAPT Study: Evaluation of 3-Month Dual Antiplatelet Therapy in High Bleeding Risk Patients Treated With a Bioabsorbable Polymer-Coated Everolimus-Eluting Stent.

34. Multicenter validation of the diagnostic accuracy of a blood-based gene expression test for assessing obstructive coronary artery disease in nondiabetic patients.

35. Hemodynamic rounds series II: hemodynamics of constrictive physiology: influence of respiratory dynamics on ventricular pressures.

Catalog

Books, media, physical & digital resources